Evaluations

in page functions

03 May 2016

2015 Full Country Evaluations report - Bangladesh

1 Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in

03 May 2016

2015 Full Country Evaluations report - Cross country

0 1 Acknowledgments The Gavi FCE team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in stakeholder consult

03 May 2016

2015 Full Country Evaluations report - Mozambique

1 2 Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved i

03 May 2016

2015 Full Country Evaluations report - Uganda

Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in st

03 May 2016

2015 Full Country Evaluations report - Zambia

1 Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in

03 May 2016

2015 FCE Cross country brief

Findings from the 2015 Gavi Full Country Evaluations CROSS-COUNTRY24, rue Salomon de Rothschild -92288 Suresnes -FRANCETl. : +33 (0)1 57 32 87 00 /Fax : +33 (0)1 57 32 87 87Web : www.carrenoir.comGAVIGAI_14_6999_LogoBlancQuad_GB30/07/2014QUIVALENCE QUADRICHROMIECYAN 40 % JAUNE 100 %CYAN 100 % MAGENTA 50 %CYAN 80 %Ce ch

18 April 2016

Summary HSS Evaluation Chad

Health System Strengthening Programme Evaluation Chad Gavi provided funding for Chad’s health system strengthening (HSS) programme from 2008-2012 but was extended beyond this period and no formal evaluation was conducted. The End of grant evaluation was requested by Gavi and the Ministry of Health (MSP) in Chad. Recogn

18 April 2016

Summary HSS Evaluation Cameroon

Health System Strengthening Programme Evaluation Cameroon Gavi provided funding for Cameroon’s health system strengthening (HSS) programme from 2007-2012 but the grant was extended and reprogramming of the HSS grant was done but no formal evaluation had been conducted. The 2015 HSS support evaluation was commissioned b

18 April 2016

Summary HSS Evaluation Afghanistan

Health System Strengthening Programme Evaluation Afghanistan Gavi provided funding for Afghanistan's health system strengthening (HSS) programme from 2008-2013. The 2013 HSS support evaluation was commissioned by the government of Afghanistan and conducted by Governance Institute-Afghanistan. Recognising that achieving

18 April 2016

Summary HSS Evaluation Yemen

Health System Strengthening Programme Evaluation Republic of Yemen Gavi provided funding for Yemen’s health system strengthening (HSS) programme from 2007-2013. The 2014 HSS support evaluation was commissioned by the government of Yemen and conducted by Sharon Beatty and Musaid Almagribi. BACKGROUND Recognising that ac

18 April 2016

Summary HSS Evaluation Tajikistan

Health System Strengthening Programme Evaluation Tajikistan Gavi provided funding for Tajikistan’s health system strengthening (HSS) programme from 2008-2014. The 2014 HSS support evaluation was commissioned by Gavi and conducted by Curatio International Foundation. BACKGROUND Recognising that achieving immunisation co

18 April 2016

Summary HSS Evaluation Sudan

Health System Strengthening Programme Evaluation Sudan Gavi provided funding for Sudan’s health system strengthening (HSS) programme from 2008-2013. The 2015 HSS support evaluation was commissioned by the Government of Sudan and conducted by Abebe Alebachew and Shahd Osman. BACKGROUND Recognising that achieving immunis

18 April 2016

Summary HSS Evaluation Nepal

Health System Strengthening Programme Evaluation Nepal Gavi provided funding for Nepal’s health system strengthening (HSS) programme through a pooled funding mechanism from 2010-2014. The 2015 HSS support evaluation was commissioned by Gavi and conducted by CEPA and HERD. BACKGROUND Recognising that achieving immunisat

18 April 2016

Summary HSS Evaluation Myanmar

Health System Strengthening Mid-term Programme Evaluation Myanmar Gavi provided funding for Myanmar’s health system strengthening (HSS) programme from 2012-2015. The 2013 mid-term evaluation of the HSS support programme was commissioned by the government of Myanmar and conducted by the Ministry of Health and the World

18 April 2016

Summary HSS Evaluation Madagascar

Health System Strengthening Programme Evaluation Madagascar Gavi provided funding for Madagascar’s health system strengthening (HSS) programme from 2008-2013. The 2014 HSS support evaluation was commissioned by Gavi and conducted by John Snow, Inc. BACKGROUND Recognising that achieving immunisation coverage is dependen

18 April 2016

Summary HSS Evaluation Ghana

Health System Strengthening Programme Evaluation Ghana Gavi provided funding for Ghana’s health system strengthening (HSS) programme from 2007-2013. The 2015 HSS support evaluation was commissioned by the government of Ghana and conducted by Tettey & Associates. BACKGROUND Recognising that achieving immunisation covera

18 April 2016

Summary HSS Evaluation Ethiopia

Health System Strengthening Programme Evaluation Ethiopia Gavi provided funding for Ethiopia’s health system strengthening (HSS) programme from 2006-2012. The 2014 HSS support evaluation was commissioned by Gavi and conducted by JaRco Consulting PLC. BACKGROUND Recognising that achieving immunisation coverage is depend

18 April 2016

Summary HSS Evaluation Eritrea

Health System Strengthening Programme Evaluation Eritrea Gavi provided funding for Eritrea’s health system strengthening (HSS) programme from 2010-2014. The 2015 HSS support evaluation was commissioned by the Government of Eritrea and conducted by ECOSOC. BACKGROUND Recognising that achieving immunisation coverage is d

18 April 2016

Summary HSS Evaluation Burkina Faso

Health System Strengthening Programme Evaluation Burkina Faso Gavi provided funding for Burkina Faso’s health system strengthening (HSS) programme from 2008-2012. The 2014 HSS support evaluation was commissioned by Gavi and conducted by SERSAP, USI, and CHUM. BACKGROUND Recognising that achieving immunisation coverage

18 April 2016

Summary HSS Evaluation Somalia

Health System Strengthening Programme Evaluation Somalia Gavi provided funding for Cameroon’s health system strengthening (HSS) programme from 2011-2015 but the grant was extended and reprogramming of the HSS grant was done but no formal evaluation had been conducted. The 2015 HSS support evaluation was commissioned by

18 April 2016

Tajikistan HSS Evaluation Report

Assessment of GAVI Support to Health System Strengthening in Tajikistan RFP No: AGSHST16062014 Final Report 16 September 2014Table of Contents Table of Contents .................................................................................................................................... 2 Acronyms ...............

18 April 2016

Nepal HSS Evaluation Report

GAVI ALLIANCE EVALUATION OF GAVI HEALTH SYSTEMS STRENGTHENING SUPPORT TO NEPAL THROUGH THE POOLED FUNDING MECHANISM 31ST MARCH 2015 FINAL REPORT Submitted by: Cambridge Economic Policy Associates Ltd In association with: Health Research and Social Development Forum CONTENTS Acronyms and abbreviations ..................

18 April 2016

Madagascar HSS Evaluation Report

Evaluation of the Gavi Health Systems Strengthening Support to Madagascar Evaluation Report 26 August 2015 John Snow, Inc. 1616 Fort Myer Drive, 16th Floor Arlington, VA 22209 USA Tel +1 703 528 7474 2 Table of Contents LIST OF TABLES AND FIGURES................................................................... 3 AC

18 April 2016

Ethiopia HSS Evaluation Report

Global Alliance for Vaccines and Immunisation, Health System Support, Ethiopia, 2006-2012 Final Evaluation GAVI Alliance JaRco Consulting PLC Addis Ababa, Ethiopia 30thSeptember 2014 2 3 List of Tables ....................................................................................................... 5 List of Figu

18 April 2016

Burkina Faso HSS Evaluation Report

EVALUATION REPORT BURKINA FASO MAY 2014 EVALUATION OF GAVI SUPPORT TO HEALTH SYSTEM STRENGTHENING IN BURKINA FASO Abel Bicaba Ludovic Queuille Slim Haddad Drissa Sia 2 SUMMARY MANDATEAND METHODS The mandate concerns the evaluation of GAVI support for health system strengthening in Burkina Faso focusing on the different

18 April 2016

Yemen HSS Evaluation Report

Final Evaluation of the GAVI Alliance Health System Strengthening Project (2007-2013) in the Republic of Yemen Final Report Sharon Beatty Musaid Almagribi April 14, 2014 1 Table of Contents Acknowledgements 2 List of Acronyms 3 Executive Summary 4 CHAPTER 1: BACKGROUND 6 I. Project description 6 II. Evaluation methodol

18 April 2016

Myanmar HSS Evaluation Report

PERFORMANCE ASSESSMENT OF GAVI-HSS INTERVENTIONS IN 20 TOWNSHIPS 2nd April 2014 Ministry of Health, World Health Organization, Country Office for Myanmar, International Health Policy Program, Thailand. Performance assessment of GAVI‐HSS interventions in 20 townships. Yangon, 2014. World Health Organization 2014 All ri

18 April 2016

Eritrea HSS Evaluation Report

1 Government of the State of Eritrea Ministry of Health GAVI HSS -END OF GRANT EVALUATION ECOSOC September 2015 i Acknowledgement The evaluation team would like to express its appreciation and sincere thanks to the Director General of the Policy, Planning and HRD -Dr. Andom Ugbamariam and his staff. Special thanks also

18 April 2016

Afghanistan HSS Evaluation Report

E v a l u a t i o n o f t h e G A V I A l l i a n c e F u n d e d H e a l t h S y s t e m S t r e n g t h e n i n g P r o g r a m 1 P a g e G o v e r n a n c e I n s t i t u t e -A f g h a n i s t a n ( G I -A ) COUNTRY EVALUATION REPORT EVALUATION OF THE GAVI ALLIANCE FUNDED HEALTH SYSTEM STRENGTHENING PROGRAM AFGHAN

18 April 2016

Chad HSS Evaluation Report

1 2 Contents ..................................................................................................................................................................... 1 Acknowledgments ...........................................................................................................................

18 April 2016

Ghana HSS Evaluation Report

GHS-GAVI Evaluation 2015 Page 0 GAVI HSS/ISS/CSO SUPPORT EVALUATION FINAL REPORT October, 2015 GHS-GAVI Evaluation 2015 Page 1 ACKNOWLEDGEMENTS The Evaluation Team (Tettey & Associates) gratefully acknowledges the support and role of various institutions, and individuals to the success of the assignment. We wish to exp

18 April 2016

Cameroon HSS Evaluation Report

Acknowledgment ....................................................................................................................................... 5 List of acronyms...................................................................................................................................... 7 Summary ......

18 April 2016

Gavi HSS meta-review report

GAVI, THE VACCINE ALLIANCE META-REVIEW OF COUNTRY EVALUATIONS OF GAVI’S HEALTH SYSTEM STRENGTHENING SUPPORT 18 MARCH 2016 FINAL REPORT Submitted by: Cambridge Economic Policy Associates Ltd CONTENTS Acronyms and abbreviations ..............................................................................................

18 April 2016

Somalia HSS Evaluation Report

EVALUATION OF THE GAVI, THE VACCINE ALLIANCE SUPPORT TO HEALTH SYSTEM STRENGTHENING IN SOMALIA Evaluation conducted by: SCHOOL OF HUMANITIES AND SOCIAL SCIENCES UNIVERSITY OF ZAMBIA LUSAKA ZAMBIA FEBRUARY 2016 Contact details: Room 133 HSS Building PO BOX 32379 Great east road Lusaka Zambia Tel. +260211290475 Email: ec

18 April 2016

Sudan HSS Evaluation Report

Evaluation of Gavi Health Systems Support 2008-2013 in Sudan Abebe Alebachew and Shahd Osman 20 October 2015 iv Contents Acronyms and Abbreviations ...................................................................................................... vi Map of Sudan .....................................................

10 March 2016

Second annual Full Country Evaluations report (2014) – Gavi response

Second annual Full Country Evaluations report (2014) – Gavi response

26 February 2016

Pneumococcal AMC outcomes and impact evaluation - Summary

A summary of the Advance Market Commitment Pilot for Pneumococcal Vaccines: Outcomes and impact evaluation.

26 February 2016

Pneumococcal AMC impact evaluation Gavi management response

Gavi Secretariat management response to the outcomes and impact evaluation of the Pilot Advance Market Commitment for Pneumococcal Vaccines.

26 February 2016

Pneumococcal AMC outcomes and impact evaluation

The report assesses the extent to which the Advance Market Commitment (AMC) Pilot for Pneumococcal Vaccines has achieved its stated objectives and the overarching goal of reducing morbidity and mortality from pneumococcal disease. The evaluation also captures lessons learned.

20 July 2015

Findings from the 2014 Gavi Full Country Evaluation - Uganda

This brief presents findings for Uganda from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

20 July 2015

Lessons Learned from the 2014 Gavi Full Country Evaluations - HPV vaccine

This brief presents lessons learned from human papillomavirus (HPV) vaccine demonstration in Mozambique and preparation for HPV national introduction in Uganda during the 2014 period of the Gavi Full Country Evaluations (FCE).

20 July 2015

Findings from the 2014 Gavi Full Country Evaluation - Bangladesh

This brief presents findings for Bangladesh from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

20 July 2015

Findings from the 2014 Gavi Full Country Evaluation - Mozambique

This brief presents findings for Mozambique from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

20 July 2015

Gavi Full Country Evaluation 2014 Annual Dissemination Report

This report presents findings from the 2014 Gavi Full Country Evaluations (FCE).

20 July 2015

Findings from the 2014 Gavi Full Country Evaluation - Zambia

This brief presents findings for Zambia from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

20 January 2015

Final evaluation of GAVI Alliance support to Bosnia and Herzegovina: Management Response

The Vaccine Alliance’s responses to key recommendations are outlined in the accompanying Management Action Plan.

15 January 2015

Final evaluation of GAVI Alliance support to Bosnia and Herzegovina

This report presents the lessons learnt and recommendations from an evaluation of Gavi’s support to Bosnia and Herzegovina and its transition after funding ended. The evaluation was conducted by the Curatio International Foundation in 2014.

15 January 2015

EAC assessment of the Evaluation of the GAVI Alliance Co-financing Policy

Gavi, the Vaccine Alliance Board Evaluation Advisory Committee (EAC) assessment of the quality and usefulness of the Norwegian Institute of Public Health’s "Evaluation of the Gavi Alliance Co-‐financing Policy".

03 July 2014

Process evaluation of Pneumococcal Vaccine Introduction – GAVI Alliance Response

Process evaluation of Pneumococcal Vaccine Introduction – GAVI Alliance Response.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 10

03 July 2014

Process evaluation report of Pneumococcal Vaccine Introduction in Mozambique, Uganda and Zambia

Process evaluation report of Pneumococcal Vaccine Introduction in Mozambique, Uganda and Zambia.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 134

31 March 2014

GAVI FCE Annual Progress Report

This report is the first annual progress report for the Full Country Evaluations project. It summarises work done in 2013 and evaluation activities to be taken forward in 2014.

  • Total pages:
  • 64

04 April 2013

GAVI-Government of China Hepatitis B vaccination programme - Evaluation Report

Evaluation of GAVI-Government of GAVI-Government of China Hepatitis B vaccination programme (2013, Abt Associates).

04 April 2013

GAVI-Government of China Hepatitis B vaccination programme - Management Response

The GAVI Secretariat’s management response to the evaluation of GAVI-Government of China Hepatitis B vaccination programme (2012, Abt Associates).

18 March 2013

GAVI Gender Policy Evaluation Report with Annexes

EVALUATION OF GAVI GENDER POLICY FINAL REPORT 14 December 2012 Submitted to: GAVI Alliance 2, Chemin des Mines 1211, Geneva 2 Switzerland Submitted by: ICF Macro, Inc. 11785 Beltsville Drive, Suite 300 Calverton, MD 20705 USAi TABLE OF CONTENTS Table of Contents i Acronyms and Abbreviations iii Executive Summary iv Key

18 March 2013

GAVI Gender Policy Recommendations Report

EVALUATION OF GAVI GENDER POLICY KEY RECOMMENDATIONS 14 December 2012 Submitted to: GAVI Alliance 2, Chemin des Mines 1211, Geneva 2 Switzerland Submitted by: ICF Macro, Inc. 11785 Beltsville Drive, Suite 300 Calverton, MD 20705 USA1 INTRODUCTION The GAVI Alliance public-private partnership brings together key stakehol

18 March 2013

GAVI Gender Policy Evaluation Management Action Plan

MANAGEMENT ACTION PLAN – EVALUATION OF THE GAVI ALLIANCE GENDER POLICY Date: 28 February 2013 1 Theme Recommendation Management Action Timeline/Responsibility Rationale, Design and Planning 1 Revision to gender policy: update rationale, strategic directions and commitments GAVI should commence a Gender Policy revision

06 March 2013

AMC Process and Design Evaluation Full Report

1 The Advance Market Commitment for Pneumococcal Vaccines Process and Design Evaluation Full Report February 15, 2013 Contents Preface ..................................................................................................................................................... 3 Acronyms and Abbreviations ......

06 March 2013

AMC Process and Design Evaluation Mgt Response

Page 1 of 2 GAVI Secretariat Management Response to the Process and Design Evaluation of the Pilot Advance Market Commitment for Pneumococcal Vaccines Advance Market Commitments (AMCs) for vaccines aim to encourage the development and production of affordable vaccines tailored to the needs of developing countries. Foll

06 March 2013

AMC Process and Design Evaluation Appendix Feb 2013

The Advance Market Commitment for Pneumococcal Vaccines Process and Design Evaluation Appendix February 15, 2013 Contents Appendix ............................................................................................................................................ 2 Appendix I. Timelines and inputs to design pro

24 September 2012

GAVI CSO evaluation_Ethiopia Country Report

GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2012 COUNTRY EVALUATION REPORT -ETHIOPIA Prepared by: Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations .............................................................................................. iii Exec

24 September 2012

GAVI CSO evaluation_Pakistan Country Report

GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2012 COUNTRY EVALUATION REPORT -PAKISTAN Prepared by: Anita Zaidi with specific inputs from Ayesha Khan and support from: Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations ...................................

24 September 2012

GAVI CSO evaluation_DRC Country Report

ŀ GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2012 COUNTRY EVALUATION REPORT -DRC Prepared by: Eliot Putnam, CEPA Associate and Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations .........................................................................

24 September 2012

GAVI CSO Evaluation_CEPA Recommendations Paper

ŀ GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CSOS 3 February 2012 RECOMMENDATIONS PAPER Prepared by: CEPA LLP CONTENTS Acronyms and abbreviations ................................................................................................ i 1. Introduction ..........................................................

24 September 2012

GAVI CSO evaluation_CEPA Evaluation Report Annexes

ŀ GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CSOS 17 January 2012 EVALUATION REPORT (ANNEXES) Prepared by: CEPA LLP CONTENTS Annex 1: Glossary.................................................................................................................. 1 Annex 2: Bibliography and data sources .....................

24 September 2012

GAVI CSO evaluation_Afghanistan Country Report

GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2011 COUNTRY EVALUATION REPORT -AFGHANISTAN Prepared by: Drs. Kayhan Natiq & Essa Tawfiq with support from: Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations .................................................

24 September 2012

Management response to 2011 CSO Evaluation

1 EVALUATION OF GAVI SUPPORT TO CSOs Management Response – September 2012 Theme Recommendation Management Response Timeline/Responsibility Structure of GAVI CSO Support Focus of the support 1. GAVI CSO support should be restructured as a ‘single funding stream’ rather than two separate types of support. The focus shoul

24 September 2012

GAVI CSO evaluation_Indonesia Country Report

GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2012 COUNTRY EVALUATION REPORT -INDONESIA Prepared by: Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations .............................................................................................. iii Exe

24 September 2012

GAVI CSO evaluation_CEPA Evaluation Main Report

ŀ GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CSOS 17 January 2012 EVALUATION REPORT Prepared by: CEPA LLP CONTENTS Acronyms and abbreviations ................................................................................................ i Executive summary ............................................................

05 July 2012

Accelerated Vaccine Introduction Project review: annexes

Annexes to report presenting the findings and lessons learnt from a review of the Accelerated Vaccine Introduction (AVI) Project. The review period spans from February to June 2012.

  • Author(s):
  • CEPA LLP; GAVI Alliance
  • Total pages:
  • 41

05 July 2012

Accelerated Vaccine Introduction Project review: final report

This report presents the findings and lessons learnt from a review of the Accelerated Vaccine Introduction (AVI) Project undertaken by Cambridge Economic Policy Associates (CEPA) for the GAVI Alliance. The review period spans from February to June 2012.

  • Author(s):
  • CEPA LLP; GAVI Alliance
  • Total pages:
  • 84

01 July 2011

IFFI evaluation: IFFIm donor response

Donors feel that the report presents valuable information about the goal effectiveness, costs effectiveness, and impacts in terms of lives saved by IFFIm. The evaluation shows, while highlighting constraints (size), lost opportunities (frontloading too early) and potential challenges (sustainability), that IFFIm has so far achieved impacts beyond those specifically targeted for immunisation.

  • Author(s):
  • HLSP
  • Total pages:
  • 4

01 July 2011

IFFIm evaluation: key messages

The International Financing Facility for Immunisation (IFFIm) concept is proven. IFFIm has allowed donor countries to make binding long-term commitments and convert these future cash flows into immediately available funds through the financial markets at a cost very close to that achieved by the World Bank. 

  • Author(s):
  • HLSP
  • Total pages:
  • 4

01 July 2011

IFFIm evaluation: executive summary

This evaluation was commissioned by the GAVI Secretariat, on behalf of the IFFIm Board, to assess the extent to which the IFFIm has been an effective financing mechanism to raise money for immunisation and health systems in GAVI eligible countries.

  • Author(s):
  • HLSP
  • Total pages:
  • 28

01 July 2011

IFFIm evaluation: The World Bank response

The World Bank has reviewed an evaluation report of the International Finance Facility for Immunisation (IFFIm) prepared by HLSP and dated June 2011. The World Bank provides services to IFFIm under the Treasury Management Agreement and this report substantially reviews those activities in the context of IFFIm’s overall performance as a financing vehicle.

  • Author(s):
  • HLSP
  • Total pages:
  • 2

01 July 2011

IFFIm evaluation: IFFIm Board response

This paper provides a response to the IFFIm Evaluation by the IFFIm Board of Directors. 

  • Author(s):
  • HLSP
  • Total pages:
  • 4

28 June 2011

IFFIm evaluation: GAVI Secretariat response

GAVI Secretariat response to IFFIm evaluation which assessed both IFFIm’s efficacy as a financing mechanism, as well as the extent to which IFFIm has contributed to enhancing GAVI’s impact on immunisation and health.

  • Author(s):
  • HLSP
  • Total pages:
  • 5

21 June 2011

IFFIm evaluation: full report

The IFFIm evaluation assesses the extent to which IFFIm is an effective and efficient instrument to attract long-term, predictable donor funds and to frontload money to finance GAVI Alliance support for immunisation and health systems.

  • Author(s):
  • HLSP
  • Total pages:
  • 175

20 April 2011

IFFIm evaluation: annexes

1 . A. 21 February 2011 Evaluation of the International Finance Facility for Immunisation (IFFIm) ANNEXES April 2011 HLSP, Sea Containers House, 20 Upper Ground, London SE1 9LZ, United Kingdom T +44 (0)20 7803 4545 F +44 (0)20 7803 4502, W www.hlsp.org Evaluation of the International Finance Facility for Immunisation (

  • Author(s):
  • HLSP
  • Total pages:
  • 155

03 February 2011

Second GAVI Evaluation 2006-2010

This evaluation seeks to answer two high-level questions: to what extent has the GAVI Alliance met its four Strategic Goals (SGs); and to what extent has the GAVI Alliance added value at the global and country levels, over and above what would have been accomplished without the Alliance?

  • Author(s):
  • CEPA LLP1 in association with Applied Strategies2 and Ulla Griffiths (Lecturer in Health Economics, London School of Hygiene and Tropical Medicine)
  • Review date:
  • 10 December 2010
  • Total pages:
  • 152
  • Publisher:
  • Gavi

29 October 2010

Baseline Study for pneumococcal vaccine AMC

The goal of the AMC baseline study was to establish the environment prior to the AMC with baseline estimates for a selection of indicators related to the objectives of the AMC and to model counterfactual scenarios to ascertain the potential impact of the AMC vis-a-vis traditional financial and procurement strategies.

  • Author(s):
  • Swiss Centre for International Health (SCIH)
  • Total pages:
  • 177

01 October 2010

Evaluation Advisory Committee report to the Board on the Second GAVI Evaluation

The Committee's overall assessment is that this is a credible and useful evaluation. The evaluation has yielded a number of important insights that will prove useful to the Board and Alliance as it prepares for and then implements its new strategy for the 2011-15 period.

  • Author(s):
  • GAVI Alliance Board Evaluation Advisory Committee
  • Total pages:
  • 3

13 September 2010

Supporting Paper 5: Progress against recommendations made by the Phase I Evaluation

Table presenting the key recommendations made by the Phase 1 evaluation and the GAVI Secretariat response. In addition, CEPA has interviewed Secretariat colleagues to understand progress made to date against these recommendations, which is noted in the final column labelled ‘implementation progress’.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 14

13 September 2010

Supporting Paper 4.1: Bangladesh country study report

The report provides contextual information on Bangladesh’s health and immunisation sector, and assesses the results and value add of GAVI programs in the country from the country stakeholders’ perspective.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 66

13 September 2010

Supporting Paper 10.3: SG4 report annexes

Supporting paper 10.3 of the second GAVI evaluation.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 37

13 September 2010

Supporting Paper 1: Bibliography

Bibliography to the second GAVI evaluation.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 19

13 September 2010

Second GAVI evaluation: Strategic Goal 4 report

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 4 in GAVI Phase II (2006-2010). GAVI's SG4 is: "to increase and assess the added value of GAVI as a public private global health partnership through improved efficiency, increased advocacy and continued innovation."

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 109

13 September 2010

Supporting Paper 10.2: SG3 report annexes

Supporting paper 10.2 of the second GAVI evaluation.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 72

13 September 2010

Second GAVI evaluation: List of support papers

List of supporting papers for the second GAVI evaluation.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 1

13 September 2010

Supporting Paper 7: Summary of feedback received from the questionnaire to EPI managers

Supporting paper 7 of the second GAVI evaluation.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 5

13 September 2010

Supporting Paper 4.5: Uzbekistan country study report

The report provides contextual information on Uzbekistan, in terms of its health and immunisation sector and assesses the results and value add of GAVI programs in the country.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) in partnership with the country consultant, EPOS Health Consultants for GAVI Alliance
  • Total pages:
  • 45

13 September 2010

Supporting Paper 4.4: Bolivia country study report

The report provides contextual information on Bolivia’s health and immunisation sector, and assesses the results and value add of GAVI programs from country stakeholders’ perspectives.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 56

13 September 2010

Supporting Paper 6: GAVI second evaluation survey, E-survey quantitative results summary

Supporting paper 6 of the second GAVI evaluation.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 58

13 September 2010

Supporting Paper 3: Evaluation methodology material

Supporting paper 3 of the second GAVI evaluation.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 41

13 September 2010

Second GAVI evaluation: Strategic Goal 3 report

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 3 in GAVI Phase II (2006-2010). GAVI's Strategic Goal 3 is: "to increase the predictability and sustainability of long-term financing for national immunisation programs."

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 98

13 September 2010

Supporting Paper 10.1: SG1 report annexes

This annex aims to illustrate the type, nature and extent of GAVI funding to date for strategic goal 1 programmes.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 121

13 September 2010

Supporting Paper 4.2: Mali country study report

The report provides contextual information on Mali’s health and immunisation sector, and assesses the results and value add of GAVI programs in the country.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 34

13 September 2010

Supporting Paper 8: GAVI second evaluation, Performance evaluation assessment

The document sets out progress on indicators and outputs for each of the four strategic goals as listed in the Revised GAVI Alliance Strategy 2007-10 (Annex source 2).

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 39

13 September 2010

Supporting Paper 2: List of consultations

List of consultations on the second GAVI evaluation.

 

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 5

13 September 2010

Second GAVI evaluation: Strategic Goal 1 report

 

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 1 in GAVI Phase II (2006-2010). GAVI's Strategic Goal 1 is: "to contribute to strengthening the capacity of the health system to deliver immunisation and other health services in a sustainable manner."

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 143

13 September 2010

Second GAVI evaluation: Strategic Goal 2 report

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 3 in GAVI Phase II (2006-2010). The GAVI Alliance's second strategic goal is to "Accelerate the uptake and use of underused and new vaccines and associated technologies and improve vaccine supply stability."

  • Author(s):
  • Applied Strategies in association with Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 154
 



close icon

modal window here